Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduard Tolosa

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Sleep Medicine|November 1, 2003
Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleepJoan Santamaria, Alex Iranzo, Eduard Tolosa
Sleep Medicine Reviews|April 14, 2009
The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseasesAlex Iranzo, Joan Santamaria, Eduard Tolosa
Sleep Medicine|October 2, 2007
Relation between subtype of Parkinson's disease and REM sleep behavior disorderHatice Kumru, Joan Santamaria, Eduard Tolosa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2004
Progressive supranuclear palsy syndrome induced by cleboprideJaume Campdelacreu, Hatice Kumru, Eduard Tolosa, et al.
Journal of Neurobiology|March 14, 2002
Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's diseaseSònia Marco, Esther Pérez-Navarro, Eduard Tolosa, et al.
Sleep|December 20, 2002
Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorderAlex Iranzo, Joan Santamaria, Jesús Pujol, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 25, 2014
Cutaneous autonomic denervation in Parkinson's diseaseJudith Navarro-Otano, Jordi Casanova-Mollà, Merche Morales, et al.
Clinical Neuropharmacology|March 6, 2012
Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trialLuis Pintor, Francesc Valldeoriola, Eva Baillés, et al.
Neurobiology of Disease|June 5, 2016
Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's diseasePetar Podlesniy, Dolores Vilas, Peggy Taylor, et al.
General Hospital Psychiatry|December 27, 2005
Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episodeLuis Pintor, Eva Baillès, Francesc Valldeoriola, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Sleep Medicine|November 1, 2003
Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleepJoan Santamaria, Alex Iranzo, Eduard Tolosa
Sleep Medicine Reviews|April 14, 2009
The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseasesAlex Iranzo, Joan Santamaria, Eduard Tolosa
Sleep Medicine|October 2, 2007
Relation between subtype of Parkinson's disease and REM sleep behavior disorderHatice Kumru, Joan Santamaria, Eduard Tolosa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2004
Progressive supranuclear palsy syndrome induced by cleboprideJaume Campdelacreu, Hatice Kumru, Eduard Tolosa, et al.
Journal of Neurobiology|March 14, 2002
Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's diseaseSònia Marco, Esther Pérez-Navarro, Eduard Tolosa, et al.
Sleep|December 20, 2002
Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorderAlex Iranzo, Joan Santamaria, Jesús Pujol, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 25, 2014
Cutaneous autonomic denervation in Parkinson's diseaseJudith Navarro-Otano, Jordi Casanova-Mollà, Merche Morales, et al.
Clinical Neuropharmacology|March 6, 2012
Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trialLuis Pintor, Francesc Valldeoriola, Eva Baillés, et al.
Neurobiology of Disease|June 5, 2016
Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's diseasePetar Podlesniy, Dolores Vilas, Peggy Taylor, et al.
General Hospital Psychiatry|December 27, 2005
Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episodeLuis Pintor, Eva Baillès, Francesc Valldeoriola, et al.
Pageof 6